Sedana Medical AB (publ) announces that its first pivotal US trial INSPiRE-ICU 1 has met its primary endpoint: to prove that inhaled sedation with isoflurane is an effective sedation method by establi ...
Armata believes the data suggest that AP-PA02 alone is as effective as the combination therapy of phage and antibiotics in reducing P.a. CFUs in the lung. The study data indicate the potential for ...
Monotherapy activity with inhaled KB707 provides further evidence of successful repeat administration of HSV-1 based inhaled lung gene delivery and builds on recent clinical data update for CF and AAT ...
While all skin types present their own challenges, combination skin is arguably the most difficult to manage. Combination skin means you’ve got both oily and dry spots on different areas of your ...
MannKind Corporation announces six-month results from phase 3 INHALE-1 of Afrezza inhalation powder in children and adolescents: Danbury, Connecticut Wednesday, December 18, 2024, ...
Drug/biologic-device combination products include a range of items such as drug-eluting stents (DES) for keeping arteries open, prefilled syringes (PFS) for easy injections, inhalers and ...